Leadership Team

Wa’el Hashad joined Avanir Pharmaceuticals as President and Chief Executive Officer in July 2017. Wa’el is a passionate leader with more than 25 years of experience in biopharmaceutical management, sales and marketing, within both the U.S. and...

In June 2016 Dan Dalton was named Senior Vice President and Chief Compliance Officer of Avanir Pharmaceuticals. Dan came to Avanir with more than 25 years of experience working with biopharmaceutical and medical device companies. He brings...

Aneta Ferguson joined Avanir Pharmaceuticals in January 2015 and currently serves as Executive Director, General Counsel. Under her leadership, the Law Department is responsible for counseling Avanir on FDA regulatory matters, product life cycle...

Dr. Lezotre joined Avanir Pharmaceuticals in June 2015 as Vice President, Global Regulatory Affairs. In this role Pierre-Louis leads all aspects of the Global Regulatory Affairs function. Under his leadership Pierre-Louis’ group is responsible for...

Lisa Locklear joined Avanir Pharmaceuticals in September 2018 as Vice President and Chief Financial Officer. She brings extensive operational and strategic finance leadership to oversee the financial operations of Avanir, including controllership and...

Linda MacDonald joined Avanir Pharmaceuticals as Vice President and Chief Operations Officer in January 2018 to lead and provide the strategic vision for the Avanir operations organization. Linda brings more than 20 years of U.S. and global...

Nori Maei was appointed Vice President of Business Planning and Alliance Management in March 2015. He is responsible for all aspects of the Otsuka/Avanir alliance and is also in charge of planning international aspects of the business. Nori brings...

Kelly Parker joined Avanir Pharmaceuticals in June 2015 and now leads the Human Resources and Corporate Communications functions. In this role Kelly provides leadership, strategic vision and functional expertise to her team and the company. Prior to...